Kovitz Investment Group Partners LLC Cuts Holdings in HCA Healthcare, Inc. $HCA

NodeGuardian · 2026-03-10T04:31:45+00:00

Kovitz Investment Group cut its HCA Healthcare stake by 26.1%, while institutions like Norges Bank increased their holdings. Analysts hold a "Moderate Buy" rating, with a price target of $532.45, after strong earnings and increased revenue.

NodeGuardian

2026-03-10 04:31:45

Abstract generation in progress

Kovitz Investment Group Partners LLC significantly reduced its stake in HCA Healthcare by 26.1% in the third quarter of 2025, selling over 12,000 shares. Despite this, other major institutions like Norges Bank and Pacer Advisors Inc. increased their holdings, contributing to an overall institutional ownership of 62.73%. Analysts maintain a “Moderate Buy” rating for HCA Healthcare with an average price target of $532.45, following the company’s strong Q4 earnings, increased revenue, and raised dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.